The Changing Landscape of Conflict of Interest Supports Further Study of ASCO Authorship Restrictions for Research Studies

2014 ◽  
Vol 10 (2) ◽  
pp. 149-150
Author(s):  

The American Society of Clinical Oncology's conflict of interest policy reaffirms a commitment to transparency and independence in the development and presentation of scientific and educational content as well as the responsibility to analyze, present, and discuss the most important research results with the potential to improve the lives of patients.

2013 ◽  
Vol 31 (16) ◽  
pp. 2037-2042 ◽  
Author(s):  

The American Society of Clinical Oncology's (ASCO's) new conflict of interest policy reflects a commitment to transparency and independence in the development and presentation of scientific and educational content. ASCO supports thorough and accessible disclosure of financial relationships with companies at institutional and individual levels and calls for rigorous evaluation of content in light of the information disclosed. For abstracts and articles presenting original research, ASCO holds first, last, and corresponding authors to a clear standard of independence. In imposing restrictions, the new policy focuses on the role of these authors rather than of the principal investigator(s) as in the previous policy. ASCO remains actively engaged with the broader scientific community in seeking and implementing efficient, effective approaches to conflict of interest management.


JAMA Oncology ◽  
2016 ◽  
Vol 2 (12) ◽  
pp. 1653 ◽  
Author(s):  
Aaron Boothby ◽  
Ruibin Wang ◽  
Jeremy Cetnar ◽  
Vinay Prasad

2014 ◽  
Vol 32 (28) ◽  
pp. 3197-3197 ◽  
Author(s):  
Francisco E. Vera-Badillo ◽  
Alberto Ocana ◽  
Arnoud J. Templeton ◽  
Ariadna Tibau ◽  
Eitan Amir ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document